Esperion Therapeutics
ESPR
#7628
Rank
NZ$0.51 B
Marketcap
$2.61
Share price
0.00%
Change (1 day)
-26.55%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of March 2025 (TTM): 1.01

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.8043. At the end of 2024 the company had a P/S ratio of 1.12.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.12-61.82%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.53 547.63%๐Ÿ‡บ๐Ÿ‡ธ USA
4.83 379.36%๐Ÿ‡บ๐Ÿ‡ธ USA
2.41 139.61%๐Ÿ‡บ๐Ÿ‡ธ USA
5.10 406.42%๐Ÿ‡บ๐Ÿ‡ธ USA
5.18 414.45%๐Ÿ‡บ๐Ÿ‡ธ USA
25.3 2,409.92%๐Ÿ‡บ๐Ÿ‡ธ USA